ETF Holdings Breakdown of ACAD

Stock NameACADIA Pharmaceuticals Inc
TickerACAD(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS0042251084
LEI529900O3044NO0PEA039

News associated with ACAD

Traders Purchase Large Volume of ACADIA Pharmaceuticals Call Options (NASDAQ:ACAD)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) saw unusually large options trading activity on Thursday. Stock traders purchased 2,626 call options on the company. This is an increase of 146% compared to the average daily volume of 1,068 call options. Insider Buying and Selling In other news, Director Elizabeth A. Garofalo sold 4,919 shares […] - 2025-05-09 05:38:58
Envestnet Asset Management Inc. Decreases Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Envestnet Asset Management Inc. lessened its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 10.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 106,664 shares of the biopharmaceutical company’s stock after selling 12,037 shares during the quarter. Envestnet Asset […] - 2025-04-28 07:38:49
Legal & General Group Plc Sells 2,348 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Legal & General Group Plc cut its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 1.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 133,042 shares of the biopharmaceutical company’s stock after selling 2,348 shares during the quarter. Legal & General […] - 2025-04-25 08:16:54
Cerity Partners LLC Acquires 6,173 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Cerity Partners LLC increased its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 43.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 20,459 shares of the biopharmaceutical company’s stock after acquiring an additional 6,173 shares during the quarter. […] - 2025-04-24 07:52:50
Summit Investment Advisors Inc. Buys 795 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Summit Investment Advisors Inc. grew its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 6.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,519 shares of the biopharmaceutical company’s stock after acquiring an additional 795 shares during the period. […] - 2025-04-22 08:07:11
Russell Investments Group Ltd. Reduces Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Russell Investments Group Ltd. reduced its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 25.9% during the 4th quarter, Holdings Channel reports. The fund owned 197,800 shares of the biopharmaceutical company’s stock after selling 69,139 shares during the period. Russell Investments Group Ltd.’s holdings in ACADIA Pharmaceuticals were worth $3,630,000 at the end […] - 2025-04-17 08:54:54
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives $23.93 Consensus PT from Brokerages
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the sixteen research firms that are presently covering the company, MarketBeat.com reports. Eight investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average […] - 2025-04-15 05:45:09
Geode Capital Management LLC Buys 1,569 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Geode Capital Management LLC increased its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 0.1% during the 4th quarter, Holdings Channel reports. The fund owned 2,877,109 shares of the biopharmaceutical company’s stock after acquiring an additional 1,569 shares during the period. Geode Capital Management LLC’s holdings in ACADIA Pharmaceuticals were worth […] - 2025-04-14 09:16:53
Needham & Company LLC Reiterates “Buy” Rating for ACADIA Pharmaceuticals (NASDAQ:ACAD)
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a report released on Tuesday,Benzinga reports. They currently have a $28.00 target price on the biopharmaceutical company’s stock. Needham & Company LLC’s price objective points to a potential upside of 87.17% from the company’s […] - 2025-04-10 06:12:56
Schroder Investment Management Group Sells 264,938 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Schroder Investment Management Group reduced its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 49.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 268,034 shares of the biopharmaceutical company’s stock after selling 264,938 shares during the quarter. Schroder Investment Management Group […] - 2025-04-06 08:34:50
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Acquired by Commonwealth Equity Services LLC
Commonwealth Equity Services LLC grew its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 190.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 43,341 shares of the biopharmaceutical company’s stock after acquiring an additional 28,395 shares during the period. Commonwealth Equity […] - 2025-04-03 07:18:48
Prudential Financial Inc. Invests $4.66 Million in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Prudential Financial Inc. bought a new stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 253,961 shares of the biopharmaceutical company’s stock, valued at approximately $4,660,000. Prudential Financial Inc. owned 0.15% of ACADIA Pharmaceuticals as of […] - 2025-04-01 09:04:49
Cibc World Markets Corp Invests $206,000 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Cibc World Markets Corp acquired a new stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 11,199 shares of the biopharmaceutical company’s stock, valued at approximately $206,000. Several other hedge funds have also recently added to or reduced their stakes in the stock. Natixis […] - 2025-03-27 09:08:52
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seventeen ratings firms that are currently covering the company, Marketbeat.com reports. Eight research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12 […] - 2025-03-18 06:14:49
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives $24.00 Average Price Target from Analysts
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen analysts that are currently covering the company, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 […] - 2025-02-24 06:48:53

ACAD institutional holdings

The following institutional investment holdings of ACAD have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 75,215USD 1,273,390
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 12,188USD 206,343
2025-05-08 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 158,677USD 2,686,402
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 79,495USD 1,345,850
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 79,495USD 1,345,850 12.5%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 153USD 2,590
Total =405,223 USD 6,860,425
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.